-+ 0.00%
-+ 0.00%
-+ 0.00%

NeoGenomics Q1 Adj. EPS $0.01, Inline, Sales $186.672M Beat $184.509M Estimate

Benzinga·04/28/2026 20:09:56
Listen to the news
NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.01 per share which met the analyst consensus estimate. The company reported quarterly sales of $186.672 million which beat the analyst consensus estimate of $184.509 million by 1.17 percent. This is a 11.09 percent increase over sales of $168.035 million the same period last year.